Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee

Completed · Phase 2 · Has a placebo group

Conditions studied: Osteoarthritis of the Knee

In brief

The purpose of this study is to determine the efficacy of ADL5859 versus placebo and ADL5747 versus placebo in relieving pain in participants with osteoarthritis of the knee.

Key facts

Study ID

NCT00979953

Run by

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

People needed

408

Starts

2009-10-01

Expected to finish

2010-06-01

Last updated by the study team

2015-08-14

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Covance CRU, Inc — Daytona Beach, Florida, United States
• Atlanta Knee and Shoulder Clinic, PC — Stockbridge, Georgia, United States
• University Rheumatoloty Center for Clinical Research — Chicago, Illinois, United States
• Clinical Investigation Specialists, Inc — Gurnee, Illinois, United States
• Cresent Medical Research — Salisbury, North Carolina, United States
• New Hanover Medical Research — Wilmington, North Carolina, United States
• Columbus Clinical Research — Columbus, Ohio, United States
• PSB Research — Mount Gilead, Ohio, United States
• Bone Joint & Spine Surgeons, Inc — Toledo, Ohio, United States
• Radient Research — Anderson, South Carolina, United States
• Quality Research — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.